KDR and neoplasm: In recent years, researchers have been trying to restrict the growth of tumor by restraining the combination between VEGF and VEGFR to stop the activation of the downstream pathway.3,5 The targeted therapy of anti-VEGF/VEGFR includes reducing the concentration of activated and freed VEGF and cutting off the VEGFR signal system.